![Cornelius S. Sobel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cornelius S. Sobel
Keine laufenden Positionen mehr
Karriereverlauf von Cornelius S. Sobel
Ehemalige bekannte Positionen von Cornelius S. Sobel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dragonfly Sciences, Inc.
![]() Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | General Counsel | 11.04.2012 | - |
Corporate Officer/Principal | 22.08.2011 | 11.04.2012 | |
MERCK KGAA | General Counsel | - | - |
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | 22.08.2011 | - |
Ausbildung von Cornelius S. Sobel
The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Statistik
International
Deutschland | 3 |
Schweiz | 2 |
Vereinigte Staaten | 2 |
Operativ
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERCK KGAA | Health Technology |
Private Unternehmen | 2 |
---|---|
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
Dragonfly Sciences, Inc.
![]() Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Health Technology |
- Börse
- Insiders
- Cornelius S. Sobel
- Erfahrung